Keratoconjunctivitis clinical trials
The registry lists 27 studies for Keratoconjunctivitis across more than 10 countries. 3 are recruiting or about to start. 16 of them are mainly about Keratoconjunctivitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-22. Counting its narrower condition Keratoconjunctivitis Sicca too: 110 studies, 4 open.
Get an email when these change. Save the Keratoconjunctivitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Taiwan University Hospital (3) · Mitotech, SA (3) · Astellas Pharma Inc (2) · Glaukos Corporation (1) · Center For Sight (1) · Rapid Pathogen Screening (1) · Johns Hopkins University (1) · Panoptes Pharma GmbH (1)
What is being tested here
Drugs under test in Keratoconjunctivitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tacrolimus | 0 | 2 | 2 |
| Cyclosporine | 0 | 0 | 1 |
| Ganciclovir | 0 | 0 | 1 |
| RVA576 | 0 | 0 | 1 |
Drug classes tested here Calcineurin inhibitors 3
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Dec 2026Corneal Topography in Vernal Keratoconjunctivitis · Assiut University
- Dec 2026Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome · Center For Sight
Who these studies take
Of the 2 Keratoconjunctivitis studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 2 (100%) | 2 (100%) |
| 75 | 2 (100%) | 2 (100%) |
| 85 | 2 (100%) | 2 (100%) |
Across all 27 studies, recruiting or not: 15% stop at 75 or younger and 11% at 65; 37% take children; 0% are for women only and 0% for men only; 19% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 27 of 27. search them.
- Evaluating a New Therapy for Dry Eye in Patients With Sjögren's SyndromeRecruitingNCT07277257Phase 41 country
- Corneal Topography in Vernal KeratoconjunctivitisNot yet recruitingNCT067464671 country
- Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)RecruitingNCT04296864Phase 21 country
- Tolerability Comparison of Flarex to Lotemax SMCompletedNCT07588074Phase 41 country
- Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis DiseaseActive, not recruitingNCT05123014Not applicable1 country
- Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/22 countries
- Ocular Comorbidity in Atopic DermatitisActive, not recruitingNCT049733841 country
- OCT Evaluation of Neurotrophic Ulcer Following Treatment With OxervateStatus unknownNCT045736471 country
- A Phase I Study of PP-001 Eye Drops in Healthy Adult VolunteersCompletedNCT03769454Phase 11 country
- AONDA Therapeutic Indication Study ICompletedNCT058911061 country
- Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseCompletedNCT05119920Phase 21 country
- Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye SyndromeCompletedNCT04206020Phase 31 country
- Study of SkQ1 as Treatment for Dry-eye SyndromeCompletedNCT03764735Phase 31 country
- A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral ConjunctivitisCompletedNCT00921895Not applicable1 country
- A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)CompletedNCT02121301Phase 21 country
- Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEECompletedNCT034798531 country
- Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry EyeCompletedNCT02313454Not applicable1 country
- Application of Real-time PCR Platform for Detection of Vittaforma Corneae Among Patients With Microsporidia KeratitisWithdrawnNCT035516391 country
- Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral KeratoconjunctivitisStatus unknownNCT04041856Phase 1/2
- Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye DropsCompletedNCT03706443Not applicable1 country
- Clinical Feature and Treatment of Microsporidial KeratoconjunctivitisStatus unknownNCT035554091 country
- Long-term Topical Cyclosporine for Atopic KeratoconjunctivitisCompletedNCT00987467Not applicable1 country
- A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus ConjunctivitisCompletedNCT01533480Phase 41 country
- Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567762Phase 31 country
- Efficacy and Safety of GV 550 in Acute Adenovirus KeratoconjunctivitisCompletedNCT01156025Phase 21 country
- Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal KeratoconjunctivitisCompletedNCT00567918Phase 31 country
- The Pathogenesis of Superior Limbic KeratoconjunctivitisStatus unknownNCT001670501 country